Cargando…
华氏巨球蛋白血症的临床特征及预后:单中心临床数据报道
OBJECTIVE: To summarize the clinical characteristics and prognosis of 51 patients with Waldenström's macroglobulinemia (WM) and evaluate the efficacy and adverse reactions of ibrutinib in the treatment of WM. METHODS: We carried out a single-center retrospective study, including 51 patients wit...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840552/ https://www.ncbi.nlm.nih.gov/pubmed/33445850 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.12.009 |
Ejemplares similares
-
巨球蛋白血症患者临床特征和预后并与Pivotal研究比较
Publicado: (2021) -
华氏巨球蛋白血症患者的临床特征、MYD88(L265P)、CXCR4(WHIM)突变和预后:单中心93例回顾性分析
Publicado: (2017) -
Ⅱ型冷球蛋白血症的临床特征及预后
Publicado: (2021) -
地塞米松、利妥昔单抗联合环磷酰胺治疗18例华氏巨球蛋白血症临床分析
Publicado: (2018) -
意义未明的单克隆丙种球蛋白血症的临床特征及疾病进展相关因素分析
Publicado: (2023)